NIT
AERI

NumerixS Investment Technologies’s Aerie Pharmaceuticals AERI Stock Holding History

NumerixS Investment Technologies’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,900
Closed -$115K – 1306
2019
Q2 		$115K Buy
+3,900
New +$150K 0.03% 561
2015
Q4 		– Sell
-11,100
Closed -$197K – 896
2015
Q3 		$197K Buy
+11,100
New +$201K 0.02% 603

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

NumerixS Investment Technologies's AERI Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Aerie Pharmaceuticals (AERI) in Q3 2019, closing a stake of 3,900 shares — an estimated $115K sold.

NumerixS Investment Technologies first reported a position in AERI in Q3 2015 and held it in 2 quarters. The position peaked at $197K in Q3 2015. 167 funds tracked by Wall St. Rank hold AERI as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Aerie Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 3,900 Aerie Pharmaceuticals shares in Q3 2019, an estimated $115K.
  • NumerixS Investment Technologies first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • NumerixS Investment Technologies's Aerie Pharmaceuticals position peaked at $197K in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.